Dexcom G7 and slim X2: Elevated Connectivity
DexCom Inc., a leader in continuous glucose monitoring (CGM), has announced a groundbreaking integration between the Dexcom G7 Continuous Glucose Monitoring (CGM) System and the Slim X2 insulin pump by Tandem Diabetes Care in the United States. This collaboration signifies the first Automated Insulin Delivery (AID) integration with the Dexcom G7 CGM, known for its unparalleled accuracy in the CGM market.
Industry Leadership and Integration Prowess
Jake Leach, executive vice president and chief operating officer at Dexcom, underscores their legacy in CGM connectivity and as the top choice for AID systems. With over a decade of experience, Dexcom stands as the sole company to have powered AID systems securely for more than 1 million patient-years, solidifying their commitment to reliable and cutting-edge technology.
Tip: Please fill out the form if you or a friend would like more information on glucose monitors.
Clinical Validation and Enhanced Outcomes
The COMISAIR seven-year follow-up study, the longest real-world CGM study conducted, showcased sustained reductions in HbA1c and a lowered risk of diabetic retinopathy progression in Type 1 diabetes patients using real-time CGM.
Furthermore, when Dexcom CGM integrated with the Tandem slim X2 insulin pump featuring Control-IQ technology, notable reductions in HbA1c were observed, indicating promising outcomes in diabetes management.
Must Read CGMs in noncritical care hospitals optimizes glycemic control
Professional Endorsement and User Impact
Dr. Nicholas Argento, MD FACE, attests to the tangible benefits of combining AID systems with real-time CGM. He highlights increased time within target glucose ranges, fewer hypoglycemic incidents, and an overall improvement in the well-being of individuals managing diabetes, substantiated by burgeoning clinical evidence.
Advanced Capabilities of Dexcom G7
Dexcom G7 emerges as the smallest, most accurate CGM system currently available, showcasing a rapid 30-minute sensor warm-up once connected to the slim X2 pump. With predictive urgent low soon alerts and no need for fingersticks from day one, Dexcom G7 users can seamlessly share real-time glucose data with loved ones and healthcare teams for remote monitoring.
Accessibility and Launch Strategy
Tandem will provide instructions via email to in-warranty slim X2 users in the U.S., enabling them to access the new feature through remote software updates at no cost. Dexcom G7 and slim X2 are compatible with each pump and are accessible through Durable Medical Equipment (DME) distributors, with pharmacy availability slated for early January 2024.
Also, read about Under-Skin Implant Offers Hope
Global Impact and Connected Ecosystem
This collaboration further strengthens Dexcom’s global connectivity in the CGM realm, boasting over 60 connected partners worldwide. Dexcom prioritizes user choice and flexibility, offering integration not only with Tandem’s slim X2 but also with various other insulin delivery systems, digital health apps, and popular lifestyle devices, ensuring a comprehensive and accessible diabetes management ecosystem.
Read Guide about Wegovy Dosage Guide: The Best Way For Weight Loss
Future Expansion Beyond Borders
The anticipated launch of Dexcom G7 and slim X2 insulin pump connectivity in additional countries beyond the U.S. is scheduled for early 2024, aiming to broaden the global reach of advanced CGM and AID integration in diabetes care.
